首页> 外国专利> CELL DEATH INDUCER, CELL PROLIFERATION INHIBITOR, AND PHARMACEUTICAL COMPOSITION FOR TREATING DISEASE ASSOCIATED WITH ABNORMAL CELL PROLIFERATION

CELL DEATH INDUCER, CELL PROLIFERATION INHIBITOR, AND PHARMACEUTICAL COMPOSITION FOR TREATING DISEASE ASSOCIATED WITH ABNORMAL CELL PROLIFERATION

机译:细胞死亡诱导剂,细胞增殖抑制剂和药物组合物,用于治疗与异常细胞增殖相关的疾病

摘要

It becomes possible to induce cell death of cancer cells and inhibit cell proliferation of cancer cells. A medicinal agent capable of inhibiting both of GST-π and MRPL17 is contained as an active ingredient, or a medicinal agent capable of inhibiting GST-π and a medicinal agent capable of inhibiting MRPL17 are contained as active ingredients.
机译:可以诱导癌细胞的细胞死亡并抑制癌细胞的细胞增殖。包含能够抑制GST-π和MRPL17两者的药物作为活性成分,或者包含能够抑制GST-π的药物和能够抑制MRPL17的药物作为活性成分。

著录项

  • 公开/公告号WO2017222035A1

    专利类型

  • 公开/公告日2017-12-28

    原文格式PDF

  • 申请/专利权人 NITTO DENKO CORPORATION;

    申请/专利号WO2017JP23121

  • 发明设计人 TANAKA HIROYUKI;MINOMI KENJIROU;

    申请日2017-06-23

  • 分类号A61K45;A61K31/7088;A61K31/7105;A61K31/713;A61K45/06;A61K48;A61P35;A61P43;

  • 国家 WO

  • 入库时间 2022-08-21 12:46:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号